The acquisition of Bolt Medical by Boston Scientific is likely to positively impact BSX's stock price in the short term as it expands its cardiovascular portfolio with a differentiated technology. This strategic move aligns with the company's goals to address coronary and peripheral diseases, potentially increasing its market share and revenue.